Also trades as: DRTSW (NASDAQ) · $vol 0M
DRTS NASDAQ
Alpha Tau Medical Ltd
1W: -9.3%
1M: +9.3%
3M: +50.9%
YTD: +152.8%
1Y: +304.3%
3Y: +206.0%
5Y: +24.6%
$11.55
-0.66 (-5.41%)
Weekly Expected Move ±11.6%
$10
$11
$12
$14
$15
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$1.0B
52W Range2.87-14.11
Volume905,937
Avg Volume929,054
Beta1.17
Dividend—
Analyst Ratings
Company Info
CEOUzi Sofer
Employees121
SectorHealthcare
IndustryMedical - Equipment & Services
IPO Date2021-03-08
Websitealphatau.com
Kiryat HaMada St. 5
Jerusalem, JM 9777605
IL
Jerusalem, JM 9777605
IL
972 3 577 4115
About Alpha Tau Medical Ltd
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company is headquartered in Jerusalem, Israel.
Latest News
Alpha Tau Medical (NASDAQ:DRTS) Trading 7.1% Higher – Here’s Why
New Strong Sell Stocks for July 7th
New Strong Sell Stocks for July 2nd
Raphi Levy sale: 17,500 shares disclosed for Alpha Tau Medical (DRTS) - Stock Titan
Alpha Tau Medical (DRTS) Looks Fully Priced After Its Glioblastoma Treatment Milestone - simplywall.st
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Levy Raphi | M-Exempt | 2,270 | $2.98 | 2026-07-06 |
| Levy Raphi | S-Sale | 2,270 | $14.00 | 2026-07-06 |
| Levy Raphi | M-Exempt | 17,873 | $2.98 | 2026-07-02 |
| Levy Raphi | S-Sale | 17,873 | $13.00 | 2026-07-02 |
| Levy Raphi | M-Exempt | 2,127 | $2.98 | 2026-07-01 |